High levels of two blood biomarkers during infection could predict cognitive dysfunction, or "brain fog," among COVID-19 survivors 6 and 12 months after hospitalization, according to a UK study published yesterday in Nature Medicine. The findings, the authors…
All of the indicators that the Centers for Disease Control and Prevention (CDC) uses to track COVID-19 activity increased in recent week, amid growing proportions of newer XBB variants, especially EG.5. In other COVID developments,…
Today two studies on COVID-19 mortality in US and Canadian cancer patients were published in JAMA Oncology and JAMA Network Open. In JAMA Oncology, research shows US cancer patients suffered higher rates of COVID-19 mortality during the Omicron wave,…
Two new US studies explore mpox epidemiologic factors, with one showing that sexual activity remains an important route of exposure among patients not reporting male-to-male sexual contact (MMSC), and another finding that 1.3% of cases in…
Two more countries—Sweden and Canada—reported their first BA.2.86 sequences to databases, as Denmark and the United Kingdom reported more detections and as New York City reported the virus in wastewater samples. Scientists and health officials…
A core component of the treatment regimen for drug-resistant tuberculosis (DR-TB) is now available to nearly 100 low-resources countries at a significantly cheaper price. The news was announced today by the Stop TB Partnership, which said pharmaceutical…
JAMA Network Open yesterday published a US cohort study showing an increase of hospital-onset COVID-19 cases when community-onset infections were high during the first 2 years of the pandemic. The authors said the findings mean increased in-hospital surveillance…
Patients diagnosed as having long COVID and myalgic encephalitis/chronic fatigue syndrome (ME/CFS) reported that most symptoms remained severe up to 20 months after SARS-CoV-2 infection, while those with long COVID alone reported improvement, according to…
Hospitalized US patients who had a type of heart attack called non–ST segment elevation myocardial infarction (NSTEMI) were at a 51% higher risk of death by 30 days and 32% higher risk of release to non-home settings amid COVID-19 patient…
When US Food and Drug Administration (FDA) inspectors visited Integra LifeSciences' drug manufacturing facility in Boston in March through May, the company's collagen-based Durepair product failed bacterial endotoxin testing. The FDA issued a warning letter to the…
